Lion Biotechnologies Inc : Lion Biotechnologies reports third quarter 2016 financial results and provides corporate update . Says Q3 adjusted loss per share of $0.17 . Qtrly loss per share $1.15 . Company appoints new CFO, Greg Schiffman .Company plans to initiate Phase 2 trials for LN-145 for potential treatment of head and neck and cervical cancers in 2017.
Microbix Biosystems Inc - : Microbix Biosystems Inc - Jim Currie is joining company on November 1, 2016 as newly appointed chief financial officer . Microbix Biosystems Inc - Charles Wallace, company's chief financial officer, is retiring on December 31, 2016 .Microbix appoints new chief financial officer.
Medpace Holdings Inc :Medpace Holdings - On October 27, board increased size of board from six to seven directors, elected Bruce Brown as a Class I director - SEC filing.
Kalobios Pharmaceuticals Inc : Kalobios Pharmaceuticals -Appointed David L. Tousley as interim chief financial officer of company, effective on October 14, 2016 . Kalobios Pharmaceuticals Inc - Tousley replaces Dean "KIP" Witter III - SEC filing Source: (http://bit.ly/2e80v7h) Further company coverage: [KBIO.PK] ((firstname.lastname@example.org;)).
Adverum Biotechnologies Inc : Adverum Biotechnologies, Inc. announces new executive chair and CEO . Says Amber Salzman appointed CEO .Adverum Biotechnologies Inc says Paul B. Cleveland has been appointed executive chairman of board.
Agile Therapeutics Inc : On October 5, 2016, board appointed Al Altomari, president and CEO, as chairman of board effective immediately - SEC filing Source: (http://bit.ly/2dOmS1B) Further company coverage: [AGRX.O] ((email@example.com;)).
Actinogen Medical Ltd : Jason Loveridge will be appointed interim chairman until an appropriate replacement is identified . Chairman, Martin Rogers, announced he will retire from board .Search will commence immediately for a replacement chairman for Actinogen Medical.
Anteo Diagnostics Ltd : Peter Harding-Smith, B BUS, CA appointed group chief financial officer .Harding-Smith will take over from Richard Martin.
Lion Biotechnologies Inc : Says appointment of Gregory T. Schiffman, as chief financial officer of company, effective immediately .Lion Biotechnologies appoints Gregory Schiffman as chief financial officer.
Immunovaccine Inc : Has begun process of hiring a new CFO . Immunovaccine announces transition of chief financial officer role . Chief financial officer (CFO) Kimberly Stephens is departing company .Stephens will continue to work with Immunovaccine through December 2016.